Results: Immunopositive cells against iNOS, 3-NT and the synthases of RSS were significantly increased only in the ACO group compared with the other groups. The levels of RSS in the sputum were significantly decreased in the ACO group compared with the other groups. The amounts of IL-8 and MCP-1 were significantly increased in the ACO group compared with the other groups. Furthermore, the nitrosative stress markers and the levels of RSS were significantly correlated with the data of lung function.
oxidants occurred in the airways of patients with ACO and it might be related to the pathogenesis. Background and Aims: Trimethylamine-N-oxide has been considered as an important regulator of bronchial asthma by improving airway inflammation, however the mechanism of Trimethylamine-N-oxide involved in improving airway inflammation remains not fully understood. In the present study, we investigated the effect of Trimethylamine-N-oxide on autophagy secondary to bronchial asthma in the lung tissues of OVA-OVA mice and in bronchial epithelial cell models.
Methods: Trimethylamine-N-oxide was administered in OVA-OVA mice and in tunicamycin-induced mouse bronchial epithelial cells, and autophagy markers were assessed via real-time PCR and western blot.
Results:
The injections of Trimethylamine-N-oxide in OVA-OVA mice exhibited down-regulation of inflammatory cytokines and airway hyperresponsiveness, and improved airway inflammation compared with OVA-OVA mice receiving vehicle. Meanwhile, the administration of Trimethylamine-N-oxide reversed autophagic dysfunction. In accordance with these findings in vivo, Trimethylamine-N-oxide treatment also had a protective impact in bronchial epithelial cell in the presence of tunicamycin by regulation of mammalian target of rapamycin (mTOR) signalling.
Conclusion: Trimethylamine-N-oxide inhibits autophagy and improves airway inflammation in the lung tissues of OVA-OVA Mice and in bronchial epithelial cell models, which may be a promising therapeutic strategies of bronchial asthma. Background and Aims: Currently, it is undeniably proven that obesity increases the risk of developing bronchial asthma and worsens control over it. Patients with asthma on the background of obesity are more often hospitalized and need higher volumes of drug therapy than patients with asthma and normal body weight. The ventilation capacity of the lungs in patients with asthma in combination with obesity is currently insufficiently studied. The purpose of the study is to examine the state of external respiration function in patients with bronchial asthma depending on the body mass by spirometry and body plethysmography.
Methods: The study included 67 patients with asthma of mild severity of partially controlled course (mean age 43. AE .5 years), 30 of them had normal body weight and 37-obesity of 1 degree. The control group consisted of 15 volunteers without bronchopulmonary pathology and obesity the study of respiration function was performed on the apparatus Master Screen Body (Care Fusion, Germany).
Results: It was found that the lung function parameters in patients with asthma with normal body weight did not differ significantly from the control group. In patients asthma with obesity, according to spirography, a decrease in the forced expiratory volume after 1 second (FEV1) and the ratio of FEV1 to forced lung capacity (FVC) by 14 % (P = 0.001) compared with the control group, which is characteristic of obstructive disorders of . In these patients, according to body pletismography, the residual volume (RV) was increased by 31% (P = 0.03) and the ratio of RV to the total lung capacity (TLC) was increased by 20 % (P = 0.03) compared to the control group, which indicates the dysfunction of the small respiratory tract and the formation of "air traps".
Conclusion:
Thus, in patients with asthma of mild severity in combination with obesity, signs of bronchial obstruction and the dysfunction of the small respiratory tract were revealed. 
